US 11,854,698 B2
Remote diagnostic testing and treatment
Michael W. Ferro, Jr., Palm Beach, FL (US); Sam Miller, Hollywood, FL (US); Colman Thomas Bryant, Fort Lauderdale, FL (US); Zachary Carl Nienstedt, Wilton Manors, FL (US); Marco Magistri, Miami, FL (US); Adam Charles Carlson, Miami, FL (US); Igor Javier Rodriguez, Miami, FL (US); James Thomas Heising, Richland, WA (US); and John Ray Permenter, Miami, FL (US)
Assigned to EMED LABS, LLC, Miami, FL (US)
Filed by EMED LABS, LLC, Miami, FL (US)
Filed on Feb. 17, 2023, as Appl. No. 18/171,113.
Application 18/171,113 is a continuation of application No. 17/700,141, filed on Mar. 21, 2022, granted, now 11,615,888.
Claims priority of provisional application 63/266,233, filed on Dec. 30, 2021.
Claims priority of provisional application 63/266,158, filed on Dec. 29, 2021.
Claims priority of provisional application 63/202,723, filed on Jun. 22, 2021.
Claims priority of provisional application 63/202,028, filed on May 24, 2021.
Claims priority of provisional application 63/179,101, filed on Apr. 23, 2021.
Claims priority of provisional application 63/164,669, filed on Mar. 23, 2021.
Prior Publication US 2023/0207115 A1, Jun. 29, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. G16H 40/67 (2018.01); G16H 20/10 (2018.01); G16H 10/60 (2018.01); G16H 50/20 (2018.01); G06T 19/00 (2011.01); G06K 19/06 (2006.01)
CPC G16H 40/67 (2018.01) [G06T 19/006 (2013.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 50/20 (2018.01); G06K 19/06028 (2013.01); G06K 19/06037 (2013.01)] 6 Claims
OG exemplary drawing
 
1. An augmented-reality (AR)-enabled drug testing kit, comprising:
a container that is a medical diagnostic test kit,
a drug test kit comprising a plurality of drug testing items that is located within the container, wherein each of the plurality of drug testing items comprises equipment necessary to perform a drug test, and
a machine-readable code located on an external surface of the container, the machine-readable code configured to be imaged by a camera of a portable user computing device to enable:
providing a fiducial point from which a coordinate frame for an augmented reality presentation can be established using the camera and a display of the portable user computing device;
causing the portable user computing device to display a user-selectable graphic on the display of the portable user computing device that, when selected by a user, causes a software application stored on the portable user computing device to access a provider webpage that enables initiation of the augmented reality presentation; and
based upon selection of the user-selectable graphic, causing display of the augmented reality presentation, wherein the augmented reality presentation comprises, for the drug test kit, a virtual representation of the drug test kit and a corresponding user-selectable graphic that, when selected, causes display of augmented reality (AR) content related to the drug test kit and the plurality of drug testing items, wherein the AR content comprises:
an indication of whether the plurality of drug testing items located within the container are sufficient to test for a drug, wherein the drug is determined based on user input provided by the user on the portable use computing device; and
an identification of a location of one or more drug testing items from the plurality of drug testing items, the one or more drug items being drug testing items that are able to test for the drug.